Aaron FTrial Shows Promise in Reducing Ventilation Time in Critically Ill Patients — FDA Grants Emergency…A recent trial, conducted by Liberate Medical, found the use of the Ventfree Respirator Muscle Stimulant reduced the overall stay time in…May 6, 2020May 6, 2020
Aaron FCandida Albicans Biofilm-Associated Resistance: Novel Liposomal Delivery System Fights BackResearchers have found promise in inhibiting the formation of biofilms in C. albicans, known to create tolerance to many of the current…Apr 29, 2020Apr 29, 2020
Aaron FAcute Coronary Syndrome: Picking the Right P2Y12 Receptor BlockerThe treatment of acute coronary syndrome (ACS) has had varying therapy strategies over the years. Due to the seriousness of the condition…Apr 22, 2020Apr 22, 2020
Aaron FThyroid Eye Disease and the Need for Alternative Therapies: Enter TepezzaPatients with Thyroid Eye Disease no longer need to wait. The FDA has recently approved the drug Tepezza (teprotumumab-trbw) for the…Apr 15, 2020Apr 15, 2020
Aaron FLandiolol Shows Promise in Sepsis-Related TachyarrhythmiasA newly published randomized control trial, highlighting the efficacy and safety of landiolol in sepsis-related tachyarrhythmia, has shown…Apr 15, 2020Apr 15, 2020
Aaron FBarhemsys (Amisulpride): The Newest Drug for Post-Operative Nausea and VomitingOn February 26th, 2020 the FDA approved Barhemsys (amisulpride) for the prevention of post-operative nausea and vomiting (PONV) in adult…Apr 8, 2020Apr 8, 2020